CTLA4 and neoplasm: Inhibition of distant tumor by IR/iDC and this effect was enhanced by the addition of anti‐CTLA‐4; survival rate has also been improved with tumor‐specific interferon‐γ‐producing T cells and cytotoxic T‐cell activity